- Home
- IGI vs COYA Comparison
IGI vs COYA Comparison
Compare IGI & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IGI
- COYA
- Stock Information
- Founded
- IGI 2009
- COYA 2020
- Country
- IGI United States
- COYA United States
- Employees
- IGI N/A
- COYA N/A
- Industry
- IGI Investment Managers
- COYA Biotechnology: Pharmaceutical Preparations
- Sector
- IGI Finance
- COYA Health Care
- Exchange
- IGI Nasdaq
- COYA Nasdaq
- Market Cap
- IGI 100.9M
- COYA 107.0M
- IPO Year
- IGI N/A
- COYA 2022
- Fundamental
- Price
- IGI $16.81
- COYA $6.16
- Analyst Decision
- IGI
- COYA Strong Buy
- Analyst Count
- IGI 0
- COYA 4
- Target Price
- IGI N/A
- COYA $16.50
- AVG Volume (30 Days)
- IGI 33.9K
- COYA 104.1K
- Earning Date
- IGI 01-01-0001
- COYA 11-05-2025
- Dividend Yield
- IGI 4.79%
- COYA N/A
- EPS Growth
- IGI N/A
- COYA N/A
- EPS
- IGI N/A
- COYA N/A
- Revenue
- IGI N/A
- COYA $423,452.00
- Revenue This Year
- IGI N/A
- COYA N/A
- Revenue Next Year
- IGI N/A
- COYA N/A
- P/E Ratio
- IGI N/A
- COYA N/A
- Revenue Growth
- IGI N/A
- COYA N/A
- 52 Week Low
- IGI $15.13
- COYA $4.65
- 52 Week High
- IGI $17.79
- COYA $10.24
- Technical
- Relative Strength Index (RSI)
- IGI 61.21
- COYA 46.61
- Support Level
- IGI $16.67
- COYA $5.78
- Resistance Level
- IGI $16.90
- COYA $6.53
- Average True Range (ATR)
- IGI 0.12
- COYA 0.40
- MACD
- IGI 0.02
- COYA -0.06
- Stochastic Oscillator
- IGI 78.49
- COYA 30.31
About IGI Western Asset Investment Grade Defined Opportunity Trust Inc.
Western Asset Invstm Grd Dfnd Opp Tr Inc operates as a non-diversified closed-end management investment company. Its primary investment objective is to provide current income and then liquidate & distribute substantially all of the Fund's net assets to stockholders. As a secondary investment objective, the Fund will seek capital appreciation. The Fund seeks to achieve its investment objectives by investing at least 80% of its net assets in investment-grade corporate fixed-income securities of varying maturities.
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.